In its battle with the coronavirus, Japan appears to be doing everything wrong. It has tested just 0.185 percent of its population, its social distancing has been halfhearted, and a majority of Japanese are critical of the government’s response. Yet with among the lowest death rates in the world, a medical system that has avoided an overloading crisis, and a declining number of cases, everything seems to be going weirdly right.
Étiqueté : Nikkei Asian Review
Drugmaker aims for trials this year with eventual goal of 10 million doses
Japanese drugmaker Shionogi & Co. said Monday that it is developing a coronavirus vaccine with the help of insects and aiming to start clinical trials this year.